Mitotic kinesin inhibitors

Details for Australian Patent Application No. 2003297230 (hide)

Owner Merck & Co., Inc.

Inventors Fraley, Mark E.; Garbaccio, Robert M.

Agent Spruson & Ferguson

Pub. Number AU-B-2003297230

PCT Number PCT/US2003/0401

PCT Pub. Number WO2004/058148

Priority 60/435,102 20.12.02 US

Filing date 16 December 2003

Wipo publication date 22 July 2004

Acceptance publication date 26 November 2009

International Classifications

C07D 211/70 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/96 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

6 May 2004 Complete Application Filed

  Priority application(s): 60/435,102 20.12.02 US

26 August 2004 Application Open to Public Inspection

  Published as AU-B-2003297230

26 November 2009 Application Accepted

  Published as AU-B-2003297230

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

25 March 2010 Standard Patent Sealed

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003297231-Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1

2003297229-SYSTEM AND METHOD FOR DISTRIBUTED AUTHORIZATION FOR ACCESS TO COMMUNICATIONS DEVICE